LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
HCWB HCW Biologics
- 0.420
- +0.002+0.48%
Close Dec 27 16:00 ET
- 0.412
- -0.008-1.98%
Post 20:01 ET
18.71MMarket Cap-0.42P/E (TTM)
0.439High0.380Low355.76KVolume0.410Open0.418Pre Close148.23KTurnover1.34%Turnover RatioLossP/E (Static)44.54MShares2.52052wk High-1.88P/B11.12MFloat Cap0.27652wk Low--Dividend TTM26.47MShs Float7.775Historical High--Div YieldTTM14.12%Amplitude0.276Historical Low0.416Avg Price1Lot Size
HCW Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 47.64%-2.93M | 48.23%-4.86M | 0.94%-3.6M | -116.77%-22.51M | -2.78%-3.89M | -141.46%-5.59M | -249.16%-9.39M | -128.51%-3.64M | 5.37%-10.39M | -12.22%-3.79M |
| Net income from continuing operations | 20.98%-3.9M | -254.99%-15.28M | -47.28%-7.47M | -67.74%-24.99M | -97.10%-10.68M | -26.17%-4.94M | -22.61%-4.3M | -146.48%-5.07M | -15.85%-14.9M | -70.75%-5.42M |
| Operating gains losses | ---- | ---- | ---- | ---15.63K | --0 | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -53.70%128.45K | -54.30%129.93K | -18.52%243.5K | 58.14%1.14M | 5.13%274.55K | 68.84%277.45K | 90.09%284.33K | 109.30%298.85K | 32.06%717.85K | 143.02%261.16K |
| Other non cash items | --0 | --0 | -300.00%-418 | -179.99%-1.67K | -200.00%-626 | -200.00%-627 | -200.00%-627 | 0.00%209 | -92.61%2.09K | --626 |
| Change In working capital | 155.57%614.93K | 281.91%10.05M | 242.19%3.38M | -286.61%-4.64M | -12.89%1M | -201.72%-1.11M | -1,573.08%-5.52M | 899.48%986.71K | 70.96%2.49M | 252.36%1.15M |
| -Change in receivables | 209.28%3.13K | 154.77%248.91K | 283.03%631.87K | -292.72%-1.12M | -1,228.74%-825.68K | 66.74%-2.87K | -320.54%-454.48K | 139.28%164.97K | -112.03%-284.7K | 1.37%-62.14K |
| -Change in prepaid assets | 162.25%125.24K | 107.32%401.17K | 66.02%302.64K | -294.04%-4.82M | 8.71%683.42K | -1,994.85%-201.19K | -1,233.74%-5.48M | -86.79%182.29K | 188.69%2.48M | 201.74%628.67K |
| -Change in payables and accrued expense | 159.33%486.56K | 1,801.51%9.4M | 247.65%2.5M | 287.21%1.62M | 97.45%1.23M | -171.64%-820.12K | 278.66%494.25K | 167.10%718.68K | -77.85%418.21K | 951.96%621.19K |
| -Change in other current liabilities | --0 | --0 | 28.63%-56.54K | -154.78%-326.74K | -114.00%-83.75K | -113.92%-82.5K | -113.84%-81.27K | -531.63%-79.23K | ---128.25K | ---39.14K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 47.64%-2.93M | 48.23%-4.86M | 0.94%-3.6M | -116.77%-22.51M | -2.78%-3.89M | -141.46%-5.59M | -249.16%-9.39M | -128.51%-3.64M | 5.37%-10.39M | -12.22%-3.79M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.40%-37.06K | 101.19%18.57K | 56.82%-129.71K | -74.18%3.8M | -5,309.54%-3.72M | 37.52%9.37M | -11,959.46%-1.56M | -103.77%-300.39K | 142.00%14.71M | -187.35%-68.69K |
| Net PPE purchase and sale | 94.12%-37.06K | 101.19%18.57K | 56.82%-129.71K | 39.63%-6.2M | -5,309.54%-3.72M | 93.80%-630.05K | -11,959.46%-1.56M | -1,175.30%-300.39K | -21,640.32%-10.28M | -246.00%-68.69K |
| Net investment purchase and sale | ---- | ---- | ---- | -59.97%10M | --0 | ---- | ---- | ---- | 171.44%24.98M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.40%-37.06K | 101.19%18.57K | 56.82%-129.71K | -74.18%3.8M | -5,309.54%-3.72M | 37.52%9.37M | -11,959.46%-1.56M | -103.77%-300.39K | 142.00%14.71M | -187.35%-68.69K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 31,576.24%2.8M | 24,807.64%1.92M | 222,022.78%4.22M | -100.23%-14.53K | 61.73%-15.25K | -100.14%-8.9K | 28.53%7.71K | -16.37%1.9K | -87.27%6.27M | -753.00%-39.85K |
| Net issuance payments of debt | 31,281.84%2.8M | --1.92M | --1.72M | -100.59%-38.27K | ---29.29K | ---8.98K | --0 | --0 | --6.45M | --0 |
| Net common stock issuance | --0 | --0 | 131,528.62%2.5M | 50.46%23.74K | 140.82%14.04K | -94.98%84 | 28.53%7.71K | -16.37%1.9K | -99.97%15.78K | -4.44%5.83K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.18%-190.55K | ---45.68K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 31,576.24%2.8M | 24,807.64%1.92M | 222,022.78%4.22M | -100.23%-14.53K | 61.73%-15.25K | -100.14%-8.9K | 28.53%7.71K | -16.37%1.9K | -87.27%6.27M | -753.00%-39.85K |
| Net cash flow | ||||||||||
| Beginning cash position | -84.41%1.16M | -77.79%4.08M | -83.90%3.6M | 90.32%22.33M | -57.21%11.22M | -51.69%7.45M | 1.50%18.39M | 90.32%22.33M | 38.73%11.73M | 73.38%26.22M |
| Current changes in cash | -104.32%-163.09K | 73.29%-2.92M | 112.42%488.98K | -276.78%-18.73M | -95.64%-7.63M | -65.09%3.77M | -305.70%-10.94M | -161.64%-3.94M | 223.55%10.6M | -14.83%-3.9M |
| End cash Position | -91.10%998.22K | -84.41%1.16M | -77.79%4.08M | -83.90%3.6M | -83.90%3.6M | -57.21%11.22M | -51.69%7.45M | 1.50%18.39M | 90.32%22.33M | 90.32%22.33M |
| Free cash flow | 52.35%-2.96M | 55.76%-4.84M | 5.21%-3.73M | -38.99%-28.72M | -97.26%-7.61M | 50.18%-6.22M | -305.08%-10.95M | -143.77%-3.94M | -87.44%-20.66M | -13.59%-3.86M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |